Description: PetIQ, Inc. is engaged in manufacturing and distributing pet medication and health and wellness products to the retail channel in the United States. The Company provides retail stores with third-party brands, including Frontline Plus, Heartgard Plus, PetAction Plus, Advecta II, Pet Lock Plus, Pet Lock Max, TruProfen and Heartshield. It distributes the products through veterinarian, retail and e-commerce channels. The Company offers its products in a range of categories, including Rx Medications, OTC Medications and Supplies, and Health and Wellness Products. Rx Medications offering includes heartworm preventatives, arthritis, thyroid, diabetes and pain treatments, antibiotics and other specialty medications. The Company manufactures Heart Shield Plus, version of Heartgard Plus, which prevents heartworm infection in dogs. The Company also manufactures TruProfen, the version of Rimadyl, which treats arthritis in dogs. OTC Medications and Supplies include flea and tick control products.
Home Page: petiq.com
PETQ Technical Analysis
230 East Riverside Drive
Eagle,
ID
83616
United States
Phone:
208 939 8900
Officers
| Name | Title |
|---|---|
| Mr. McCord Christensen | Chairman & CEO |
| Mr. Michael A. Smith | Pres & COO |
| Mr. Robert Michael Herrman | Exec. VP, Gen. Counsel & Corp. Sec. |
| Mr. Zvi Glasman | Chief Financial Officer |
| Mr. John Pearson | Sr. VP & Head of Services Division |
Exchange: NASDAQ
Country: US
Currency: US Dollar ($)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Health Care Equipment & Services |
| GIC Industry: | Health Care Providers & Services |
| GIC Sub-Industry: | Health Care Distributors |
| Forward PE: | 7.776 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 1.5409 |
| Price-to-Sales TTM: | 0.3449 |
| IPO Date: | 2017-07-21 |
| Fiscal Year End: | December |
| Full Time Employees: | 849 |